Fig. 1From: FOLFOX regimen after failure of fluorouracil and leucovorin plus nanoliposomal-irinotecan therapy for advanced pancreatic cancer: a retrospective observational studyKaplan-Meier curve of overall survival. The median overall survival was 3.9 months (95% confidence interval, 3.1–4.8)Back to article page